Abstract
The effect of l-5-HTP (25–400 mg/kg IP) following inhibition of the peripheral aromatic amino acid decarboxylase by means of benserazide (25 mg/kg IP) was investigated in a test modified from Vogel's drinking conflict model. At 50 mg/kg an anti-conflict action was detected, while higher doses (100–400 mg/kg) decreased punished responding. A lower dose (25 mg/kg) had no effect. Non-specific effects — such as alterations in muscle tone, in motivation to drink or in the sensitivity to electrical shock — could not explain the anxiolytic- and anxiogenic-like actions of 50 and 100 mg/kg, respectively. The bi-phasic effect of l-5-HTP is discussed in terms of different subpopulations of central serotoninergic receptors, possibly exerting opposing influences on conflict responding. The study emphasises the importance of 5-HT mechanisms in anxiety, and the possibility of finding novel anxiolytics among drugs selectively affecting central 5-HT neurotransmission.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvidsson L-E, Hacksell U, Nilsson JLG, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H (1981) 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem 24:921–923
Ceulemans DLS, Hoppenbrouwers M-LJA, Gelders YG, Reyntjens AJM (1985) The influence of ritanserin, a serotonin antagonist, in anxiety disorders: A double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303–305
Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S (1984) Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol 105:365–368
Geller J, Blum K (1970) The effects of 5-HTP on parachlorophenylalanine (pCPA) attenuation of “conflict” behavior. Eur J Pharmacol 9:319–324
Gozlan H, El Mestikawy S, Pichat L, Glowinski J, Hamon M (1983) Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature 305:140–142
Hjorth S, Carlsson A (1982) Buspirone: Effects on central monoaminergic transmission — possible relevance to animal experimental and clinical findings. Eur J Pharmacol 83:299–304
Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55:169–188
Hjorth S, Engel JA, Carlsson A (1986) Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacol Biochem Behav 24:237–240
Iversen SD (1985) 5-HT and anxiety. Neuropharmacology 23:1553–1560
Jacobs BL (1976) An animal model for studying central serotonergic synapses. Life Sci 19:777–786
Kahn RS, Westenberg HGM (1985) L-5-Hydroxytryptophan in the treatment of anxiety disorders. J Affect Dis 8:197–200
Kilts CD, Commissaris RL, Cordon JJ, Rech RH (1982) Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam. Psychopharmacology 78:156–164
Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of Ritanserin — a very potent and long-acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611
Liljequist S, Engel JA (1984) The effects of GABA or benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol. Pharmacol Biochem Behav 21:521–525
Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(di-n-propylamino)tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153
Peroutka SJ (1985) Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors. Biol Psychiatr 20:971–979
Taylor DP, Eison MS, Riblet LA, van der Maelen CP (1985) Pharmacological and clinical effects of buspirone. Pharmacol Biochem Behav 23:687–694
Traber J, Davies MA, Dompert WU, Glaser T, Schuurman T, Seidel P-R (1984) Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull 12:741–744
Tye NC, Everitt BJ, Iversen SD (1977) 5-Hydroxytryptamine and punishment. Nature 268:741–743
Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing antianxiety agents. Psychopharmacology 21:1–7
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hjorth, S., Söderpalm, B. & Engel, J.A. Biphasic effect of l-5-HTP in the Vogel conflict model. Psychopharmacology 92, 96–99 (1987). https://doi.org/10.1007/BF00215486
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00215486